Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non-Current Deffered Revenue: 2011-2012

Historic Non-Current Deffered Revenue for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $133,000.

  • Sonoma Pharmaceuticals' Non-Current Deffered Revenue rose 2028.57% to $3.0 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.0 million, marking a year-over-year increase of 2028.57%. This contributed to the annual value of $133,000 for FY2012, which is 16.87% down from last year.
  • According to the latest figures from FY2012, Sonoma Pharmaceuticals' Non-Current Deffered Revenue is $133,000, which was down 16.88% from $160,000 recorded in FY2011.
  • Over the past 5 years, Sonoma Pharmaceuticals' Non-Current Deffered Revenue peaked at $160,000 during FY2011, and registered a low of $133,000 during FY2012.
  • For the 2-year period, Sonoma Pharmaceuticals' Non-Current Deffered Revenue averaged around $146,500, with its median value being $146,500 (2011).
  • Data for Sonoma Pharmaceuticals' Non-Current Deffered Revenue shows a maximum YoY declined of 16.87% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Non-Current Deffered Revenue stood at $160,000 in 2011, then fell by 16.87% to $133,000 in 2012.